Home » Stocks » BASI

Bioanalytical Systems, Inc. (BASI)

Stock Price: $20.14 USD 1.87 (10.24%)
Updated Mar 2, 2021 4:00 PM EST - Market closed
After-hours: $20.55 +0.41 (2.04%) Mar 2, 7:55 PM
Market Cap 224.18M
Revenue (ttm) 65.44M
Net Income (ttm) -3.63M
Shares Out 11.02M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 2
Last Price $20.14
Previous Close $18.27
Change ($) 1.87
Change (%) 10.24%
Day's Open 18.78
Day's Range 18.52 - 21.08
Day's Volume 220,595
52-Week Range 3.05 - 21.08

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 6 days ago

WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 2 weeks ago

WEST LAFAYETTE, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 3 weeks ago

WEST LAFAYETTE, Ind., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 1 month ago

WEST LAFAYETTE, Ind., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 1 month ago

WEST LAFAYETTE, Ind., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider...

GlobeNewsWire - 1 month ago

WEST LAFAYETTE, Ind., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider...

GlobeNewsWire - 2 months ago

WEST LAFAYETTE, Ind., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider...

GlobeNewsWire - 2 months ago

WEST LAFAYETTE, Ind., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider...

GlobeNewsWire - 4 months ago

WEST LAFAYETTE, Ind., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of drug...

GlobeNewsWire - 5 months ago

WEST LAFAYETTE, Ind., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of non...

GlobeNewsWire - 6 months ago

WEST LAFAYETTE, Ind., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 6 months ago

WEST LAFAYETTE, Ind., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of no...

GlobeNewsWire - 9 months ago

WEST LAFAYETTE, Ind., May 14, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of noncl...

GlobeNewsWire - 9 months ago

WEST LAFAYETTE, Ind., May 05, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of non...

GlobeNewsWire - 10 months ago

WEST LAFAYETTE, Ind., April 24, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) doing business as Inotiv, a leading provider of nonc...

GlobeNewsWire - 11 months ago

WEST LAFAYETTE, Ind., March 09, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), today announced the appointment of Beth ...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), is pleased to announce the launch of its ...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) doing business as Inotiv, a leading provider of nonclinical and an...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), is pleased to announce the launch of its new contract research se...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), a leading provider of nonclinical and analytical contract researc...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of Stewart B. Jacobson, DVM, D...

GlobeNewsWire - 1 year ago

WEST LAFAYETTE, Ind., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of William D. Pitchford, BS, ...

About BASI

Bioanalytical Systems, doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This... [Read more...]

Industry
Diagnostics & Research
IPO Date
Nov 24, 1997
CEO
Robert Leasure
Employees
397
Stock Exchange
NASDAQ
Ticker Symbol
BASI
Full Company Profile

Financial Performance

In 2020, BASI's revenue was $60.47 million, an increase of 38.64% compared to the previous year's $43.62 million. Losses were -$4.69 million, 493.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for BASI stock is "Buy" and the 12-month stock price forecast is 21.00.

Price Target
$21.00
Analyst Consensus: Buy